The growing use of weight-loss drugs like Ozempic could be having an impact on supermarkets’ bottom lines as Brits shy away ...

A $10.2 million savings across more than 100,000 prescriptions over three months, extrapolated across the nearly 33 million Americans currently taking GLP-1 medications monthly, indicates a potential ...

Novo Nordisk has ended its partnership with Hims & Hers, citing concerns over the telehealth company’s promotion and sale of the drugmaker’s compounded versions of Wegovy. The drugmaker alleged that ...

Lower blood sugar and increased fat burning – without negatively affecting appetite or muscle mass. These are some of the ...

Novo Nordisk launches weightloss drug Wegovy in India at competitive prices, facing patent battles and high demand.

Trial finds weight loss drug taken monthly helps people lose 20% of body weight – but adverse GI events were ‘common’ - The ...

After decades of increases, diabetes-related health care costs have plateaued, according to a new Trends in Spend report from Nomi Health.